Asia-Pacific Ion Chromatography Mass Spectrometry Market, By Type (Systems, Software), Platform (Hybrid Mass Spectrometry, Single Mass Spectrometry, Other Platforms), Mode of Operation {(Single Ion Monitoring (SIM), Selected Reaction Monitoring (SRM), High Resolution Accurate Mass (HRAM)}, Work Flow (Electrospray Ionization (ESI), Atmospheric Pressure Chemical Ionization (APCI), Others), End User (Biotechnology Companies, Pharmaceutical Companies, Food and Beverage Companies, Contract Research Organizations, Diagnostic Centers, Forensic Laboratories, Hospitals, Academic and Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Asia-Pacific Ion Chromatography Mass Spectrometry Market Analysis and Size
In the food, pharmaceutical, and biotechnology industries, ion chromatography mass spectrometry has a wide range of uses, such as process validation, clinical testing of protein identification and quantitative drug analysis, environmental testing, proteomics, biomarker discovery, pharmacokinetics, food nutritional composition testing and others. Mass spectrometry is widely used and in high demand for drug development, which has fuelled market expansion.
Data Bridge Market Research analyses that the ion chromatography mass spectrometry market which is USD 506.00 billion in 2022 and is expected to reach USD 1,030.65 billion by 2030, at a CAGR of 9.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Ion Chromatography Mass Spectrometry Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Systems, Software), Platform (Hybrid Mass Spectrometry, Single Mass Spectrometry, Other Platforms), Mode of Operation {(Single Ion Monitoring (SIM), Selected Reaction Monitoring (SRM), High Resolution Accurate Mass (HRAM)}, Work Flow (Electrospray Ionization (ESI), Atmospheric Pressure Chemical Ionization (APCI), Others), End User (Biotechnology Companies, Pharmaceutical Companies, Food and Beverage Companies, Contract Research Organizations, Diagnostic Centers, Forensic Laboratories, Hospitals, Academic and Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
Axel Semrau GmbH & Co. KG (Germany), Bruker (U.S.), Cecil Instrumentation Services Ltd. (U.K.), General Electric (U.S.), Hitachi High-Tech America, Inc. (Japan), JASCO Corporation (Japan), KNAUER Wissenschaftliche Geräte GmbH (Germany), SEDERE (France), Sykam GmbH (Germany), Waters Corporation. (U.S.), Agilent Technologies, Inc. (U.S.), SCION Instruments (Netherlands), Gilson Incorporated. (U.S.), PerkinElmer Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Restek Corporation. (U.S.), Thermo Fisher Scientific Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Ion chromatography mass spectrometry helps with process validation and clinical testing of, among other things, pharmacokinetics, proteomics, biomarker development, food nutritional composition testing, and environmental testing as well as protein identification and quantitative medication analysis.
Asia-Pacific Ion Chromatography Mass Spectrometry Market Dynamics
Drivers
- Rising usage of ion chromatography mass spectrometry
According to a study published in March 2021 titled "Non-aqueous Ion-Exchange Chromatography Using High Acid-Base Concentration: A Strategy for Purifying Non-Crystalline Pharmaceutical Intermediates," IEX is used in non-aqueous mobile phases to purify a non-crystalline intermediate after a reductive amination with D-xylose, strength and purity of the intermediate allowing successful downstream processing. Ion chromatography is widely used in the pharmaceutical sector because the market growth is anticipated to be driven by this procedure.
- Rising funding for R&D
The National Institute of Health got USD 700 billion in federal financing over the last 20 years, according to the Congressional Budget Office, which will be released in April 2021. (NIH). The National Institutes of Health (NIH) conducts its own scientific research through the Intramural Research Program (IRP) and provides significant biomedical research funding to non-NIH research facilities through the Extramural Research Program. A sizable percentage of this funding was allocated to basic research in genomics, molecular biology, and other life sciences, which resulted in the identification of novel disease pathways. The NIH get USD 41 billion in funding by 2020, an annual increase of 1%. Ion chromatography will therefore become more widely used in R&D, spurring market expansion, as a result of increased funding for R&D in fundamental research which will drive the market growth.
Opportunities
- Increasing advancements of mass spectrometry
Mass spectrometry's latest technological advances will accelerate market expansion. Mass spectrometry technology is being modified in order to be used because of strict government restrictions for the development of foods and medicines for consumer safety as well as method validation. For instance, the FDA released a paper in May 2019 that provided a technique for finding six nitrosamine contaminants that are found in ARB medications. The best method for determining the precise value of m/z in deprotonated and protonated impurity ions is the high-mass accuracy (HRAM) mass spectrometer, also known as a high-resolution spectrometer. High-mass accuracy (HRAM) mass spectrometers are in high demand due to these FDA-described methodologies or techniques. Such regulation promotes the use of mass spectrometry in a number of industries, which is expected to drive market growth.
Restraints/Challenges
- High cost of the equipment
The main disadvantage of ion chromatography is the high cost of the equipment. Most ions determined by ion chromatography can be measured using less expensive methods.
This ion chromatography mass spectrometry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ion chromatography mass spectrometry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2019, Waters Corporation introduced new mass spectrometry equipment to address complex analytical requirements. Two brand-new mass spectrometry systems have been put on the market: Cyclic IMS and SYNAPT XS. This business strengthened their product line while also enhancing their consumer offering.
- In 2019, Thermo Fisher Scientific Inc. achieved a novel analytical workflow for ion chromatography and mass spectrometry (IC-MS/MS). The approach is designed to assist food testing facilities in overcoming the difficulties associated with LC-MS/MS, or liquid chromatography tandem analysis with mass spectrometry. They enhanced their solutions for clients in the food industry through this business.
- In 2022, Bio-Rad introduced EconoFit Chromatography Column packs, which have mixed-mode, cation, and anion exchange resin columns as well as a pack made for the purification of the polyhistidine protein.
- In 2022, Thermofisher introduced quat pesticide quantification and determination procedures to safeguard the food supply. Scientists can use it to quickly and accurately identify and quantify cationic insecticides.
Asia-Pacific Ion Chromatography Mass Spectrometry Market Scope
The ion chromatography mass spectrometry market is segmented on the basis of type, platform, mode of operation, work flow, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Systems
- Software
Platform
- Hybrid Mass Spectrometry
- Single Mass Spectrometry
- Other Platforms
Mode of Operation
- Single Ion Monitoring (SIM)
- Selected Reaction Monitoring (SRM)
- High Resolution Accurate Mass (HRAM)
Work Flow
- Electrospray Ionization (ESI)
- Atmospheric Pressure Chemical Ionization (APCI)
- Others
End User
- Biotechnology Companies
- Pharmaceutical Companies
- Food and Beverage Companies
- Contract Research Organizations
- Diagnostic Centers
- Forensic Laboratories
- Hospitals
- Academic and Research Institutes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Ion Chromatography Mass Spectrometry Market Regional Analysis/Insights
The ion chromatography mass spectrometry market is analyzed and market size insights and trends are provided by country, type, platform, mode of operation, work flow, end-user and distribution channel as referenced above.
The countries covered in the Ion chromatography mass spectrometry market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Japan dominates the Asia-Pacific ion chromatography mass spectrometry market due to increased adoption of quality control and analytical processes by the food and beverage and pharmaceutical industries.
China is anticipated to grow with the highest growth rate in the forecast period of 2023 to 2030 due to growing R&D expenditure and the strong establishment of new competitors in Asian countries. For instance, according to the European Federation of Pharmaceutical Industries and Associations, in 2017 Japan saw an overall increase in new therapeutic launches of roughly 7.1%, as a result of their significant and rising investment in the development of therapeutic proteins.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The ion chromatography mass spectrometry market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ion chromatography mass spectrometry market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ion chromatography mass spectrometry market. The data is available for historic period 2011-2021.
Competitive Landscape and Ion Chromatography Mass Spectrometry Market Share Analysis
The ion chromatography mass spectrometry market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to ion chromatography mass spectrometry market.
Some of the major players operating in the ion chromatography mass spectrometry market are:
- Axel Semrau GmbH & Co. KG (Germany)
- Bruker (U.S.)
- Cecil Instrumentation Services Ltd. (U.K.)
- General Electric (U.S.)
- Hitachi High-Tech America, Inc. (Japan)
- JASCO Corporation (Japan)
- KNAUER Wissenschaftliche Geräte GmbH (Germany)
- SEDERE (France)
- Sykam GmbH (Germany)
- Waters Corporation. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- SCION Instruments (Netherlands)
- Gilson Incorporated. (U.S.)
- PerkinElmer Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Restek Corporation. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
SKU-